Twist Bioscience shares rise after deal with Lilly’s TuneLab
Twist Bioscience said it signed a deal with Eli Lilly’s drug discovery platform Lilly TuneLab, sending TWST up 5% to $144.90 Wednesday. The stock has more than quadrupled over the past year.
Twist Bioscience shares advanced after the company said it signed a deal with Eli Lilly's drug discovery platform Lilly TuneLab. 90 Wednesday. Shares have more than quadrupled over the past year. TuneLab offers access to artificial intelligence and mac…